Skip to Content

Join the 'Hypotension' group to help and get support from people like you.

Hypotension News

Related terms: Orthostatic Hypotension, Low Blood Pressure

Health Tip: Feeling Dizzy? When to See Your Doctor

Posted 30 Aug 2018 by Drugs.com

-- Occasional dizziness should not be a major concern. But if you feel this way often and it begins to interfere with your daily life, you may have a balance disorder, the National Institutes of Health says. More than 40 percent of Americans will visit a doctor for an episode of dizziness at some point in their lives, the agency says. Common reasons for dizziness include ear infection, head...

FDA Approves Giapreza (angiotensin II) to Treat Dangerously Low Blood Pressure

Posted 26 Dec 2017 by Drugs.com

December 21, 2017 – The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock. "Shock, the inability to maintain blood flow to vital tissues, can result in organ failure and death," said Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular...

Sudden Drops in Blood Pressure Tied to Higher Odds for Dementia

Posted 11 Oct 2016 by Drugs.com

TUESDAY, Oct. 11, 2016 – There seems to be an association between sudden drops in blood pressure upon standing up – a condition called orthostatic hypotension – and an increased risk for dementia, according to a new study. The study of 6,000 Dutch people could only point to an association between sudden low blood pressure and dementia, and couldn't prove cause-and-effect. However, a...

Flamel Technologies Receives FDA Approval of Akovaz (ephedrine sulfate) for Surgical Hypotension

Posted 3 May 2016 by Drugs.com

LYON, FRANCE--(Marketwired - May 2, 2016) - Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's New Drug Application (NDA) for Akovaz™ (ephedrine sulfate), a drug administered parenterally as a pressor agent to address clinically important hypotension in surgical settings. Flamel obtained NDA approval for Akovaz as s...

Flamel Technologies Announces FDA Approval of Vazculep

Posted 3 Jul 2014 by Drugs.com

LYON, FRANCE--(Marketwired - Jun 30, 2014) - Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for Vazculep (phenylephrine hydrochloride). Vazculep Injection is an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from...

FDA Approves Northera to treat Neurogenic Orthostatic Hypotension

Posted 20 Feb 2014 by Drugs.com

February 18, 2014 – The U.S. Food and Drug Administration today approved Northera capsules (droxidopa) for the treatment of neurogenic orthostatic hypotension (NOH). NOH is a rare, chronic and often debilitating drop in blood pressure upon standing that is associated with Parkinson's disease, multiple-system atrophy, and pure autonomic failure. Symptoms of NOH include dizziness,...

Ask a Question

Further Information

Related Drug Support Groups

phenylephrine, norepinephrine, ephedrine